Lobbying

Claritev's latest lobbying report covers Q2 2026, at $130K. The four quarters Q4 2025–Q3 2026 total $440K. Its first report covers Q3 2024; the issues it reports most are Health Issues and Medicare/Medicaid.

Claritev

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$440K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q3 2024
The first quarter a report named it

Lobbying by quarter

Claritev lobbying by quarter
Claritev lobbying by quarter
QuarterAmountReports
Q3 2024$110K1
Q4 2024$130K1
Q1 2025$140K1
Q2 2025$160K1
Q3 2025$160K1
Q4 2025$150K1
Q1 2026$160K1
Q2 2026$130K1
Q3 2026$00

By issue

  • Health issues$760K · 8 reports
  • Medicare and Medicaid$380K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE8 reports
  • Centers For Medicare and Medicaid Services (CMS)5 reports
  • Executive Office of the President (EOP)1 reports

Firms it paid

Firm
In-houseClaritev$1.1M8 quarters

Former officials lobbying for it

Former position
PETER HENRYLeg Director, Sen. Dan Sullivan; Professional Staff Member, Senate Environment and Public Works Cmte; Sr Leg Assistant, Sen. Roy Blunt; Leg Assistant, Sen. Kit Bond; Leg Correspondent, Cong. Roy Blunt; Staff Assistant, Sen. Jim TalentQ4 2024

Lobbying reports

Filed by
07/17for Q2In-house$130K
04/20for Q1In-house$160K
01/16for Q4 2025In-house$150K
25/10/20for Q3 2025In-house$160K
25/07/18for Q2 2025In-house$160K
25/04/21for Q1 2025In-house$140K
25/03/03for Q3 2024In-houseUnder $5,000
25/01/27for Q3 2024In-house$110K
25/01/21for Q4 2024In-house$130K
24/09/23for Q3 2024In-houseUnder $5,000